小细胞肺癌预防性颅脑照射与主动MRI监测的均衡性探讨
本文批判性审视广泛期小细胞肺癌预防性颅脑照射(PCI)的随机试验,结合现代MRI分期与监测背景,讨论PCI省略对生存的影响及全脑中等剂量放疗的神经认知毒性,并综述放射外科治疗小细胞肺癌脑转移的前瞻性研究证据,强调需开展当代试验评估最佳中枢神经系统管理。
要点
- PCI可降低小细胞肺癌脑转移发生率,但带来可测量的神经认知功能与生活质量毒性。
- 广泛期小细胞肺癌随机试验显示,省略PCI后无进展生存等效,总生存有改善趋势。
- 现代MRI分期与监测背景下,PCI的生存优势受到挑战,需当代试验评估最佳中枢神经系统管理。
核心结论
- PCI虽一致降低小细胞肺癌脑转移发生率,但伴随可测量的神经认知功能与生活质量毒性,其历史生存优势在现代MRI分期与监测背景下受到挑战,需开展当代试验评估最佳中枢神经系统管理。
研究设计与样本
- 本文为综述性文章,批判性审视广泛期小细胞肺癌PCI的随机试验,并讨论其对MRI时代前局限期小细胞肺癌历史数据的影响,同时综述全脑中等剂量放疗毒性及放射外科治疗小细胞肺癌脑转移的前瞻性研究证据。
主要发现
- PCI可一致降低小细胞肺癌脑转移发生率,但代价是对神经认知功能和生活质量可测量的毒性,并伴有特征性脑部病理改变。
- 广泛期小细胞肺癌随机试验显示,省略PCI后无进展生存等效,总生存有改善趋势。
- PCI的后续效应历史上曾依据小细胞肺癌特有的总生存优势来合理化,但该理由现已被上述随机试验挑战。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prophylactic cranial irradiation (PCI) for SCLC offers a consistent reduction in the incidence of brain metastases at the cost of measurable toxicity to neurocognitive function and quality of life, in the setting of characteristic pathologic changes to the brain. The sequelae of PCI have historically been justified by the perception of an overall survival advantage specific to SCLC. This rationale has now been challenged by a randomized trial in extensive-stage SCLC demonstrating equivalent progression-free survival and a trend toward improved overall survival with PCI omission in the context of modern magnetic resonance imaging (MRI) staging and surveillance. In this article, we critically examine the randomized trials of PCI in extensive-stage SCLC and discuss their implications on the historical data supporting PCI for limited-stage SCLC from the pre-MRI era. Further, we review the toxicity of moderate doses of radiation to the entire brain that underlie the growing interest in active MRI surveillance and PCI omission. Finally, the evidence supporting prospective investigation of radiosurgery for limited brain metastases in SCLC is reviewed. Overall, our aim is to provide an evidence-based assessment of the debate over PCI versus active MRI surveillance and to highlight the need for contemporary trials evaluating optimal central nervous system management in SCLC.
引用
- Rusthoven CG, Kavanagh BD. Prophylactic Cranial Irradiation (PCI) versus Active MRI Surveillance for Small Cell Lung Cancer: The Case for Equipoise. J Thorac Oncol. 2017. PMID: 28882584. doi:10.1016/j.jtho.2017.08.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。